The new post-hoc analysis of MRI findings demonstrated that subclinical spinal cord lesions were associated with future NMOSD attacks, as well. UPLIZNA is the first and only targeted CD19+ B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback